GenomeNet

Database: RefSeq
Entry: NP_001230361
LinkDB: NP_001230361
Original site: NP_001230361 
LOCUS       NP_001230361             317 aa            linear   PRI 16-NOV-2023
DEFINITION  transcriptional regulator ERG isoform 6 [Homo sapiens].
ACCESSION   NP_001230361
VERSION     NP_001230361.1
DBSOURCE    REFSEQ: accession NM_001243432.2
KEYWORDS    RefSeq.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (residues 1 to 317)
  AUTHORS   Tang X, Huang J, Jiang Y, Qiu J, Li T, Li W, Chen Z, Huang Z, Yu X,
            Yang T, Ji X, Tan R, Lv L, Yang Z and Chen H.
  TITLE     Intercellular adhesion molecule 2 as a novel prospective tumor
            suppressor induced by ERG promotes ubiquitination-mediated radixin
            degradation to inhibit gastric cancer tumorigenicity and metastasis
  JOURNAL   J Transl Med 21 (1), 670 (2023)
   PUBMED   37759298
  REMARK    GeneRIF: Intercellular adhesion molecule 2 as a novel prospective
            tumor suppressor induced by ERG promotes ubiquitination-mediated
            radixin degradation to inhibit gastric cancer tumorigenicity and
            metastasis.
            Publication Status: Online-Only
REFERENCE   2  (residues 1 to 317)
  AUTHORS   Ding D, Blee AM, Zhang J, Pan Y, Becker NA, Maher LJ 3rd, Jimenez
            R, Wang L and Huang H.
  TITLE     Gain-of-function mutant p53 together with ERG proto-oncogene drive
            prostate cancer by beta-catenin activation and pyrimidine synthesis
  JOURNAL   Nat Commun 14 (1), 4671 (2023)
   PUBMED   37537199
  REMARK    GeneRIF: Gain-of-function mutant p53 together with ERG
            proto-oncogene drive prostate cancer by beta-catenin activation and
            pyrimidine synthesis.
            Publication Status: Online-Only
REFERENCE   3  (residues 1 to 317)
  AUTHORS   Schafer CM, Martin-Almedina S, Kurylowicz K, Dufton N,
            Osuna-Almagro L, Wu ML, Johnson CF, Shah AV, Haskard DO, Buxton A,
            Willis E, Wheeler K, Turner S, Chlebicz M, Scott RP, Kovats S,
            Cleuren A, Birdsey GM, Randi AM and Griffin CT.
  TITLE     Cytokine-Mediated Degradation of the Transcription Factor ERG
            Impacts the Pulmonary Vascular Response to Systemic Inflammatory
            Challenge
  JOURNAL   Arterioscler Thromb Vasc Biol 43 (8), 1412-1428 (2023)
   PUBMED   37317853
  REMARK    GeneRIF: Cytokine-Mediated Degradation of the Transcription Factor
            ERG Impacts the Pulmonary Vascular Response to Systemic
            Inflammatory Challenge.
REFERENCE   4  (residues 1 to 317)
  AUTHORS   Salles DC, Mendes AA, Han M, Partin AW, Trock BJ, Jing Y and Lotan
            TL.
  TITLE     ERG Status at the Margin Is Associated With Biochemical Recurrence
            After Radical Prostatectomy With Positive Surgical Margins
  JOURNAL   Mod Pathol 36 (7), 100147 (2023)
   PUBMED   36828362
  REMARK    GeneRIF: ERG Status at the Margin Is Associated With Biochemical
            Recurrence After Radical Prostatectomy With Positive Surgical
            Margins.
REFERENCE   5  (residues 1 to 317)
  AUTHORS   Schandl CA, Mazzoni S, Znoyko I, Nahhas GJ, Chung D, Ding Y, Hess B
            and Wolff DJ.
  TITLE     Novel high-risk acute myeloid leukemia subgroup with ERG
            amplification and Biallelic loss of TP53
  JOURNAL   Cancer Genet 272-273, 23-28 (2023)
   PUBMED   36657266
  REMARK    GeneRIF: Novel high-risk acute myeloid leukemia subgroup with ERG
            amplification and Biallelic loss of TP53.
REFERENCE   6  (residues 1 to 317)
  AUTHORS   Zammarchi F, Boutsalis G and Cartegni L.
  TITLE     5' UTR control of native ERG and of Tmprss2:ERG variants activity
            in prostate cancer
  JOURNAL   PLoS One 8 (3), e49721 (2013)
   PUBMED   23472063
  REMARK    GeneRIF: characterization of native ERG and Tmprss2:ERG variants
            reveals that their different oncogenic potential is affected by the
            status of the Ets domain and the configuration of the 5' UTR region
REFERENCE   7  (residues 1 to 317)
  AUTHORS   Peterson A, Patil N, Robbins C, Wang L, Cox DR and Myers RM.
  TITLE     A transcript map of the Down syndrome critical region on chromosome
            21
  JOURNAL   Hum Mol Genet 3 (10), 1735-1742 (1994)
   PUBMED   7849696
REFERENCE   8  (residues 1 to 317)
  AUTHORS   Rao VN, Modi WS, Drabkin HD, Patterson D, O'Brien SJ, Papas TS and
            Reddy ES.
  TITLE     The human erg gene maps to chromosome 21, band q22: relationship to
            the 8; 21 translocation of acute myelogenous leukemia
  JOURNAL   Oncogene 3 (5), 497-500 (1988)
   PUBMED   3274086
REFERENCE   9  (residues 1 to 317)
  AUTHORS   Reddy,E.S., Rao,V.N. and Papas,T.S.
  TITLE     The erg gene: a human gene related to the ets oncogene
  JOURNAL   Proc Natl Acad Sci U S A 84 (17), 6131-6135 (1987)
   PUBMED   3476934
REFERENCE   10 (residues 1 to 317)
  AUTHORS   Rao,V.N., Papas,T.S. and Reddy,E.S.
  TITLE     erg, a human ets-related gene on chromosome 21: alternative
            splicing, polyadenylation, and translation
  JOURNAL   Science 237 (4815), 635-639 (1987)
   PUBMED   3299708
COMMENT     REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from DC356222.1 and AY204741.1.
            
            Summary: This gene encodes a member of the erythroblast
            transformation-specific (ETS) family of transcriptions factors. All
            members of this family are key regulators of embryonic development,
            cell proliferation, differentiation, angiogenesis, inflammation,
            and apoptosis. The protein encoded by this gene is mainly expressed
            in the nucleus. It contains an ETS DNA-binding domain and a PNT
            (pointed) domain which is implicated in the self-association of
            chimeric oncoproteins. This protein is required for platelet
            adhesion to the subendothelium, inducing vascular cell remodeling.
            It also regulates hematopoesis, and the differentiation and
            maturation of megakaryocytic cells. This gene is involved in
            chromosomal translocations, resulting in different fusion gene
            products, such as TMPSSR2-ERG and NDRG1-ERG in prostate cancer,
            EWS-ERG in Ewing's sarcoma and FUS-ERG in acute myeloid leukemia.
            More than two dozens of transcript variants generated from
            combinatorial usage of three alternative promoters and multiple
            alternative splicing events have been reported, but the full-length
            nature of many of these variants has not been determined. [provided
            by RefSeq, Apr 2014].
            
            Transcript Variant: This variant (7) differs in the 3' exon,
            compared to variant 3. The resulting protein (isoform 6) has a
            shorter and distinct C-terminus, when it is compared to isoform 3.
            
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            
            ##Evidence-Data-START##
            Transcript exon combination :: AY204741.1 [ECO:0000332]
            RNAseq introns              :: mixed sample support SAMEA1965299,
                                           SAMEA1966682 [ECO:0006172]
            ##Evidence-Data-END##
            
            ##RefSeq-Attributes-START##
            regulatory uORF :: PMID: 23472063
            ##RefSeq-Attributes-END##
FEATURES             Location/Qualifiers
     source          1..317
                     /organism="Homo sapiens"
                     /db_xref="taxon:9606"
                     /chromosome="21"
                     /map="21q22.2"
     Protein         1..317
                     /product="transcriptional regulator ERG isoform 6"
                     /note="v-ets avian erythroblastosis virus E26 oncogene
                     related; ets-related; ERG, ETS transcription factor;
                     FUS/ERG fusion protein; v-ets erythroblastosis virus E26
                     oncogene like; transcriptional regulator ERG (transforming
                     protein ERG); TMPRSS2/ERG fusion; v-ets erythroblastosis
                     virus E26 oncogene homolog; v-ets avian erythroblastosis
                     virus E26 oncogene homolog"
                     /calculated_mol_wt=35155
     Region          134..208
                     /region_name="SAM_PNT-ERG"
                     /note="Sterile alpha motif (SAM)/Pointed domain of ERG
                     transcription factor; cd08540"
                     /db_xref="CDD:176090"
     CDS             1..317
                     /gene="ERG"
                     /gene_synonym="erg-3; LMPHM14; p55"
                     /coded_by="NM_001243432.2:273..1226"
                     /note="isoform 6 is encoded by transcript variant 7"
                     /db_xref="GeneID:2078"
                     /db_xref="HGNC:HGNC:3446"
                     /db_xref="MIM:165080"
ORIGIN      
        1 miqtvpdpaa hikealsvvs edqslfecay gtphlaktem tassssdygq tskmsprvpq
       61 qdwlsqppar vtikmecnps qvngsrnspd ecsvakggkm vgspdtvgmn ygsymeekhm
      121 pppnmttner rvivpadptl wstdhvrqwl ewavkeyglp dvnillfqni dgkelckmtk
      181 ddfqrltpsy nadillshlh ylretplphl tsddvdkalq nsprlmharn tggaafifpn
      241 tsvypeatqr ittrpdlpye pprrsawtgh ghptpqskaa qpspstvpkt edqrpqldpy
      301 qilgptssrl anpgwtq
//
DBGET integrated database retrieval system